Abstract:We have analysed the frequency of killer immunoglobulin-like receptors (KIR) in cohorts of patients from Turkey with acute lymphocyte leukaemia (n = 52), acute myeloid leukaemia (n = 54) and chronic myeloid leukaemia (CML) (n = 52) and compared the results with 154 controls. We also examined the frequencies of human leucocyte antigen (HLA)-C groups, -Bw4, -Bw6 and where appropriate the combination of the KIR gene and its ligand. We found several statistically significant results between the patients and the co… Show more
“…Carrying 2 copies of the Bw4 allele results in an almost fourfold increased risk of childhood ALL in this ethnic group. Homozygosity for Bw4 has previously been associated with increased risk of chronic myeloid leukemia, with a trend toward increased risk of both acute myeloid leukemia and ALL, 40 and we now provide evidence that this may also play a role in childhood ALL.…”
“…Carrying 2 copies of the Bw4 allele results in an almost fourfold increased risk of childhood ALL in this ethnic group. Homozygosity for Bw4 has previously been associated with increased risk of chronic myeloid leukemia, with a trend toward increased risk of both acute myeloid leukemia and ALL, 40 and we now provide evidence that this may also play a role in childhood ALL.…”
“…KIR2DL2/KIR2DS2/C1 combination was protective in chronic myeloid leukemia [25]. Other examples are cited by several comprehensive reviews, e.g., Boyton and Altmann [26] and Purdy and Campbell [27].…”
“…A recent report in patients with chronic myeloid leukemia also described a protective effect of KIR2DL2 and/or KIR2DS2 in the presence of ligand HLA-C1 and proposes a model of protection [47].…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.